Oxazolidin-2-one compounds and uses thereof

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 9458177
APP PUB NO 20140378450A1
SERIAL NO

14478523

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The present invention relates to oxazolidin-2-one substituted pyrimidine compounds that act as PI3K (phosphatidylinositol-3-kinase) inhibitors, as well as pharmaceutical compositions thereof, methods for their manufacture and uses for the treatment of conditions, diseases and disorders dependent on PI3K.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
NOVARTIS AGLICHTSTRASSE 35 BASEL 4056

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Caravatti, Giorgio Bottmingen, CH 47 823
Fairhurst, Robin Alec Riehen, CH 80 559
Furet, Pascal Thann, FR 157 2124
McCarthy, Clive Oxfordshire, GB 67 399
Rueeger, Heinrich Flueh, CH 31 298
Seiler, Frank Hans Freiburg, DE 3 18
Stauffer, Frédéric Hesingue, FR 10 118

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
11.5 Year Payment $7400.00 $3700.00 $1850.00 Apr 4, 2028
Fee Large entity fee small entity fee micro entity fee
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00